These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6418548)

  • 21. Microbial Degradation of Chlorogenic Acid by a Sphingomonas sp. Strain.
    Ma Y; Wang X; Nie X; Zhang Z; Yang Z; Nie C; Tang H
    Appl Biochem Biotechnol; 2016 Aug; 179(8):1381-92. PubMed ID: 27068831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolism of dimethylamphetamine in rat and man.
    Inoue T; Suzuki S
    Xenobiotica; 1987 Aug; 17(8):965-71. PubMed ID: 3673111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition and metabolism of darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in humans.
    Dave M; Nash M; Young GC; Ellens H; Magee MH; Roberts AD; Taylor MA; Greenhill RW; Boyle GW
    Drug Metab Dispos; 2014 Mar; 42(3):415-30. PubMed ID: 24378325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometry.
    Winter CK; Segall HJ; Jones AD
    Biomed Environ Mass Spectrom; 1988 Mar; 15(5):265-73. PubMed ID: 3365497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic studies of explosives. II. High-performance liquid chromatography-mass spectrometry of metabolites of 2,4,6-trinitrotoluene.
    Yinon J; Hwang DG
    J Chromatogr; 1985 Apr; 339(1):127-37. PubMed ID: 4019662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of oxaflozane urinary metabolism in man, the dog and the rat. Identification of the principal metabolites.
    Constantin M; Pognat JF
    Arzneimittelforschung; 1979; 29(1):109-14. PubMed ID: 582104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic fate of fenetylline in rat and man.
    Yoshimura H; Yoshimitsu T; Yamada H; Koga N; Oguri K
    Xenobiotica; 1988 Aug; 18(8):929-40. PubMed ID: 3188572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man.
    Bechtel WD; Mierau J; Brandt K; Förster HJ; Pook KH
    Arzneimittelforschung; 1986 Mar; 36(3A):578-86. PubMed ID: 3718581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolism of acetophenone oxime in rat liver homogenates.
    Hes J; Sternson LA
    Drug Metab Dispos; 1974; 2(4):345-50. PubMed ID: 4153517
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical pharmacokinetics of fluvoxamine.
    Perucca E; Gatti G; Spina E
    Clin Pharmacokinet; 1994 Sep; 27(3):175-90. PubMed ID: 7988100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.
    Riska P; Lamson M; MacGregor T; Sabo J; Hattox S; Pav J; Keirns J
    Drug Metab Dispos; 1999 Aug; 27(8):895-901. PubMed ID: 10421616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic fate of stiripentol in man.
    Moreland TA; Astoin J; Lepage F; Tombret F; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(6):654-62. PubMed ID: 2877822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
    Hamilton BA; Jones PG; Hoda AN; Keane PM; Majid I; Zaidi SI
    Pharmatherapeutica; 1989; 5(5):292-7. PubMed ID: 2501801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and mass spectrometric characterization of the major urinary and fecal metabolites of 9-methyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]-quinolizine in the rat.
    Sparatore A; Maffei Facino R; Canu Boido C; Boido V; Sparatore F; Arlandini E
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):135-44. PubMed ID: 8582439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hypokinetic rigid syndrome with fluvoxamine maleate.
    Meerwaldt JD
    Lancet; 1986 Apr; 1(8487):977-8. PubMed ID: 2871275
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biotransformation of the trapidil (rocornal) derivative AR 12463 in the rat].
    Pfeifer S; Langner A; Grahlmann D; Franke P; Gründemann E; Tenor E
    Pharmazie; 1990 Jul; 45(8):609-14. PubMed ID: 2080211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.